Summary
The generation of immunoglobulin-secreting cells upon stimulation with pokeweed mitogen was studied in patients with Hodgkin's Disease (HD) and non-Hodgkin lymphomas (NHL) using a reverse hemolytic plaque assay. The experiments revealed that the majority of the patients in both groups had greatly diminished responses of their peripheral B-lymphocytes. Whereas in NHL patients an intrinsic B-cell defect is the most likely explanation for the impaired B-cell reactivity, the situation in HD appears to be more complex. In some patients with an active stage of the disease, suppressor cells were found to cause the unresponsiveness: in other patients, an intrinsic B-cell defect as well as a defect of the T helper cells were responsible for the diminished responses. The results further suggest that the immune defect in patients with HD is reversible and can be corrected by therapy.
Similar content being viewed by others
References
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res 31: 1860–1861
Case DC, Hansen JA, Corrales E, Young CW, Dupont W, Pinsky CM, Good RA (1976) Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease. Cancer 38: 1807–1815
Cohnen G (1975) T- and B-Lymphozyten bei chronischer lymphatischer Leukämie und Lymphogranulomatose. Elektronenmikroskopische und immunologische Untersuchungen. Veröff Pathol 1–99
Corder MP, Young RC, Brown RS, De Vita VT (1972) Phytohemagglutinin-induced lymphocyte transformation: the relationship to prognosis of Hodgkin's disease. Blood 39: 595–601
Diehl V, Schaadt M, Kalden RJ, Hagedorn C, Schmidt N, Deinhardt J (1979) Der Einfluß der Splenektomie auf den Immunstatus von Hodgkin-Patienten. Klin Wochenschr 56: 809–818
Eltringham JR, Kaplan HS (1973) Impaired delayed hypersensitivity responses in 154 patients with Hodgkin's disease. Natl Cancer Inst Monogr 36: 107–115
Fahey JL (1965) Antibodies and immunoglobulin. J Am Med Assoc 194: 255–263
Fauci AS, Pratt KR (1976) Polyclonal activation of bone-marrow derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay. Proc Natl Acad Sci USA 73: 3676–3679
Fiddes P, Penny R, Wells JV, Rozenberg MC (1972) Clinical correlations with immunoglobulin levels in chronic lymphatic leukaemia. Aust NZ J Med 4: 346–357
Gershon RK (1974) T cell control of antibody production. Contemp Top Immunobiol 3: 1–40
Gorzynski RM (1974) Immunity to murine sarcoma virus-induced tumors. II. Suppression of T-cell-mediated immunity by cells from progressor animals. J Immunol 112: 1826–1838
Gronowicz E, Coutinho A, Melchers F (1976) A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol 6: 588–590
Han T, Sokal JE (1970) Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med 48: 728–734
Han T, Minowada J, Subramanian V, Barcos M, Kim U (1980) Splenic T- and B-lymphocytes and their mitogenic response in untreated Hodgkin's disease. Cancer 45: 767–774
Hansen JA, Good RA (1974) Malignant disease of the lymphoid system in immunological perspective. Hum Pathol 5: 728–754
Hersh EM, Oppenheim JJ (1965) Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med 273: 1006–1012
Hersh EM, Irvin WS (1969) Blastogenic responses of lymphocytes from patients with untreated and treated lymphomas. Lymphology 2: 150–160
Hillinger SM, Herzig GP (1978) Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest 60: 1620–1627
Katz SI, Parker D, Turk JL (1974) B-cell suppression of delayed hypersensitivity reactions. Nature 251:550–551
Kirchner H, Chused TM, Herberman RB (1974) Evidence of suppressor cell activity in spleen cells of mice bearing primary tumors induced by Maloney sarcoma virus. J Exp Med 139: 1473–1487
Kirchner H, Tosato G, Blaese RM, Broder S, Magrath IT (1979) Polyclonal immunoglobulin secretion by human B-lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol 122: 1310–1313
Lennert K (1973) Pathologisch-histologische Klassifizierung der malignen Lymphome. In: Stacher A (Hrsg) Leukämien und maligne Lymphome. Urban u Schwarzenberg, München Wien Baltimore, pp 181–194
Levy R, Kaplan HS (1974) Impaired lymphocyte function in untreated Hodgkin's disease. N EnglJ Med 290: 181–186
Lukes RJ, Collins RD (1975) New approaches to the classification of the lymphomata. Br J Cancer 31: 1–28
Papac RJ (1970) Lymphocyte transformation in malignant lymphomas. Cancer 26: 279–286
Rappaport H (1966) Tumors of the hematopoetic system. Armed Forces Inst of Pathology, Sect 3, Fasc 8. Washington DC, pp 91–156
Rühl H, Scholle H, Kirchner H (1971) Stimulation peripherer menschlicher Lymphozyten in vitro durch Zn2+ bei Patienten mit Lymphogranulomatose und chronischer lymphatischer Leukämie. Acta Haematol 76: 326–337
Rühl H, Scholle H, Bochert G, Vogt W (1978) Activation of lymphocyte subpopulations in patients with chronic lymphocytic leukemia. Z Immunitätsforsch Immunobiol 154: 75–87
Rühl H, Rühl U, Sieber G (1980) Immune alterations in patients with Hodgkin's disease. Cell Mol Biol 25: 409–414
Scheurlen PG (1972) Immunologische Probleme bei der Lymphogranulomatose. Z Krebsforsch 78: 192–205
Schier WW, Roth A, Ostroff G, Schrift MH (1956) Hodgkin's disease and immunity. Am J Med 20: 94–103
Sieber G, Bochert G, Enders B, Rühl H (1980) Characteristics of immunoglobulin secretion in man evaluated by a reverse hemolytic plaque assay. Blut 41:81–92
Siegal FP, Siegal M, Good RA (1976) Suppression of B cell differentiation by leucocytes from hypogammaglobulinemic patients. J Clin Invest 58: 109–122
Stein H (1976) Klassifikation der malignen Non-Hodgkin-Lymphome aufgrund gemeinsamer morphologischer und immunologischer Merkmale zwischen normalen und neoplastischen Zellen. Immun Infekt 4: 52–69 95–109
Twomey JJ, Laughter AH, Farrow S, Douglas CC (1975) Hodgkin's disease, an immunodepleting and immunosuppressive disorder. J Clin Invest 56: 467–475
Ultmann JW, Fish W, Osserman E, Gellhorn A (1959) The clinical implications of hypogammaglobulinaemia in patients with chronic lymphocytic leukemia and lymphocytic lymphosarcoma. Ann Intern Med 51: 501–512
Waldmann TA, Broder S, Blaese RM, Durm M, Blackman M, Strober W (1974) Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet II: 609–613
Waldmann TA, Broder S, Krakauer R, MacDermott RP, Durm M, Goldman C, Meade B (1976) The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma. Fed Proc 35: 2067–2072
Author information
Authors and Affiliations
Additional information
Supported by the Deutsche Forschungsgemeinschaft (Ru 215/2).
Rights and permissions
About this article
Cite this article
Rühl, H., Enders, B., Bur, M. et al. Impaired B-lymphocyte reactivity in patients with Hodgkin's disease and non-Hodgkin-lymphomas. Blut 42, 271–281 (1981). https://doi.org/10.1007/BF00996844
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00996844